Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases.

Purpose: To compare treatment plans and evaluate dosimetric characteristics of permanent cesium-131 (Cs) vs. iodine-125 (I) implants used in brain brachytherapy.

Material And Methods: Twenty-four patients with Cs implants from a prospective phase I/II trial were re-planned with I implants.

Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand?

Backgrounds And Aims: As treatment for esophageal cancer often involves a multidisciplinary approach, the initial endoscopic report is essential for communication between providers. Several guidelines have been established to standardize endoscopic reporting. This study evaluates the compliance of esophagogastroduodenoscopy (EGD) and endoscopic ultrasound (EUS) reporting with the current national guidelines.

Predictors of clinical outcome of colonic stents in patients with malignant large-bowel obstruction because of extracolonic malignancy.

Background And Aims: Colonic stent placement in patients with large-bowel obstruction (LBO) secondary to extracolonic malignancy (ECM) has been evaluated in small series with heterogeneous results. Our aim is to better characterize the technical and clinical success of colonic stent placement and to identify factors that affect this success in ECM patients.

Methods: All patients at a single high-volume center who presented for colonic stent placement for LBO because of ECM between 2001 and 2012 were retrospectively identified.

Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature review.

Glioblastoma is not only the most common primary brain tumor, but also the most aggressive. Currently, the most effective treatment of surgery, chemotherapy and radiation therapy allows for a modest median survival of 15 months. Here, we report a case of a 57-year-old male with histologically confirmed glioblastoma with unfavorable prognostic characteristics (poor performance status and persistent neurological symptoms after surgery), whose expected 5-year survival is 0%.